Threat of resurgence or hope for global eradication of poliovirus?

CY Kim, B Piamonte, R Allen… - Current Opinion in …, 2023 - journals.lww.com
Threat of resurgence or hope for global eradication of polio... : Current Opinion in Neurology
Threat of resurgence or hope for global eradication of poliovirus? : Current Opinion in …

mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions

R Okuyama - Vaccines, 2023 - mdpi.com
New technological platforms, such as mRNA and adenoviral vector vaccines, have been
utilized to develop coronavirus disease 2019 (COVID-19) vaccines. These new modalities …

[HTML][HTML] Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from …

OS Kumru, M Sanyal, N Friedland, JM Hickey, R Joshi… - Vaccine, 2023 - Elsevier
The development of safe and effective second-generation COVID-19 vaccines to improve
affordability and storage stability requirements remains a high priority to expand global …

Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?

CA Devaux, P Pontarotti, A Levasseur… - Frontiers in Public …, 2024 - frontiersin.org
The polioviruses (PVs) are mainly transmitted by direct contact with an infected person
through the fecal-oral route and respiratory secretions (or more rarely via contaminated …

Immune persistence after different polio sequential immunization schedules in Chinese infants

T Zhao, J Li, T Huang, ZF Ying, YC Che, ZM Zhao… - npj Vaccines, 2024 - nature.com
Trivalent oral poliovirus vaccine (tOPV) has been withdrawn and instead an inactivated
poliovirus vaccine (IPV) and bivalent type 1 and type 3 OPV (bOPV) sequential …

Development: From Traditional to Modern Approaches

M Aribi - New Topics in Vaccine Development, 2024 - books.google.com
Vaccinology, the scientific discipline focused on vaccines, has evolved from com-bating
infectious diseases to addressing a wide array of a broad spectrum of health concerns …

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate

P Kumar, M Wang, OS Kumru, JM Hickey… - … Therapy-Methods & …, 2023 - cell.com
Recombinant adeno-associated viruses (rAAVs) are a preferred vector system in clinical
gene transfer. A fundamental challenge to formulate and deliver rAAVs as stable and …

Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis …

P Kumar, DA Holland, K Secrist, P Taskar, B Dotson… - Vaccines, 2024 - mdpi.com
Introducing new recombinant protein antigens to existing pediatric combination vaccines is
important in improving coverage and affordability, especially in low-and middle-income …

[HTML][HTML] Evaluating the Compatibility of Three Aluminum Salt-Adjuvanted Recombinant Protein Antigens (Trivalent NRRV) Combined with a Mock Trivalent Sabin-IPV …

P Kumar, A Hamana, C Bird, B Dotson… - Vaccines, 2024 - mdpi.com
In this work, we describe compatibility assessments of a recombinant, trivalent non-
replicating rotavirus vaccine (t-NRRV) candidate with a mock trivalent Sabin inactivated …

Two Recombinant Cytomegalovirus Antigens Formulated with the SPA14 Adjuvant System: Impact of Temperature, pH and Excipients on the Stability of each Antigen …

JM Hickey, OS Kumru, F Dalençon, F Arvis… - Journal of …, 2025 - jpharmsci.org
By evaluating the stability profiles of each component of a vaccine candidate (antigens,
adjuvants), formulation conditions to mitigate vaccine instability can be identified. In this …